NSE: HINDUNILVR | BSE: 500696

Expensive Performer

Download real time

2498.60 -18.90 (-0.75%)

888.7K NSE+BSE Volume

NSE 08 Aug, 2025 3:31 PM (IST)

587,068.9

Market Cap

Market Leader

0.5

Beta 1Year

Very Low volatility

Hindustan Unilever Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for HINDUNILVR, BSE:500696 Hindustan Unilever Ltd.

Hindustan Unilever Ltd.

24 Jul 2024

2498.60

-0.75%

Result Update:Hind. Unilever

Buy: Hindustan Unilever Ltd.

Target

Axis Direct

With an 10% upside from the CMP, we maintain our long-term BUY rating on the stock.

Hindustan Unilever L.. has an average target of 2817.10 from 10 brokers.

Hindustan Unilever Ltd.

24 Jul 2024

2498.60

-0.75%

Transforming to outperform; execution starting to fall in place

Buy: Hindustan Unilever Ltd.

Recommendation Target

Emkay

We remain positive on HUL, on hope of better execution by the new leadership. The management emphasized that its strategies are aimed at transforming the company to outperform, which will pave the way to growth recovery in segments.

Sharekhan increased Buy price target of Hindustan Unilever Ltd. to 2832.0 on 01 Aug, 2025.

Hindustan Unilever Ltd.

24 Jul 2024

2498.60

-0.75%

Hindustan Unilever (BUY): Sales growth in line; expect rebound in 2H

Buy: Hindustan Unilever Ltd.

Target

BOB Capital Markets Ltd.

Sales growth of 2% YoY was in line with Bloomberg consensus. Underlying volumes rose 4% on Home Care & Personal Care (Hair Care)

Number of FII/FPI investors decreased from 1904 to 1221 in Jun 2025 qtr

Hindustan Unilever Ltd.

24 Jul 2024

2498.60

-0.75%

Growth picks up, new formulation in soaps holds margin potential; Buy

Buy: Hindustan Unilever Ltd.

Anand Rathi

With revenue up 1.3% (vs. the Street’s 1.2% estimate) and volumes rising 4% (3%), HUL’s Q1 was broadly in line with estimates. Rural demand uptick, innovations and premiumisation aided Q1.

Number of MF schemes decreased from 403 to 50 in Jun 2025 qtr

Hindustan Unilever Ltd.

23 Jul 2024

2498.60

-0.75%

Volume growth on recovery path

Buy: Hindustan Unilever Ltd.

Target

Sharekhan

HUL’s Q1FY2025 performance was in line with expectations with revenues and PAT growing by 1.3% and 3% y-o-y, respectively; underlying volume growth came in at 4%.

Number of FII/FPI investors decreased from 1904 to 1221 in Jun 2025 qtr

Hindustan Unilever Ltd.

23 Jul 2024

2498.60

-0.75%

HINDUSTAN UNILEVER

Hold: Hindustan Unilever Ltd.

Target

Prabhudas Lilladhar

Hindustan Unilever L.. has an average target of 2817.10 from 10 brokers.

Hindustan Unilever Ltd.

23 Jul 2024

2498.60

-0.75%

In-line show; earnings to further improve in 2HFY25

Buy: Hindustan Unilever Ltd.

Target

Motilal Oswal

Hindustan Unilever’s (HUVR) 1QFY25 performance was in line with our estimates. Net sales rose 2% YoY, with 4% volume growth (est. 3%).

Hindustan Unilever Ltd. is trading above all available SMAs

Hindustan Unilever Ltd.

27 Jun 2024

2498.60

-0.75%

Subdued year gone by; on a comeback trail

Buy: Hindustan Unilever Ltd.

Target

Sharekhan

We maintain a Buy on Hindustan Unilever Limited (HUL) with an unchanged PT of Rs. 2,725. Likely revival in rural India and its underperformance versus broader indices makes HUL a preferred pick in the consumer goods space. Stock trades at 53x and 47x its FY25E and FY26E EPS, respectively

Number of MF schemes decreased from 403 to 50 in Jun 2025 qtr

Hindustan Unilever Ltd.

26 Jun 2024

2498.60

-0.75%

Journey toward sustainable growth

Buy: Hindustan Unilever Ltd.

Target

Motilal Oswal

Hindustan Unilever’s (HUVR) FY24 annual report provides insights about its key focus areas to build upon its sustainable growth model

Number of MF schemes decreased from 403 to 50 in Jun 2025 qtr

Hindustan Unilever Ltd.

29 Apr 2024

2498.60

-0.75%

First Light | Maruti Suzuki, Hindustan Unilever, Bajaj Finance, SBI Life, Supreme Industries, Dalmia Bharat, UTI AMC, Glenmark Life Sciences

Buy: Hindustan Unilever Ltd.

Target

BOB Capital Markets Ltd.

MSIL: Steady performance, but steep valuations; downgrade to HOLD. HUVR: Subdued performance; expect gradual recovery. BAF: Obstacles for a powerful player on a protracted journey. SBILIFE: Expect market dominance to continue. SI: In-line Q4FY24; pipe volume guided to grow at healthy rate in FY25. DALBHARA: Disappointments all over; but paving the way for growth. UTIAM: Core profit in line; maintain HOLD. GLS: Weak quarter; maintain HOLD

Number of MF schemes decreased from 403 to 50 in Jun 2025 qtr

Is Hindustan Unilever Ltd. worth buying?

2463 Votes:

Buy 71.58%

Sell 16.36%

Hold 12.06%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf